BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 3311622)

  • 1. Quantitative studies on menstrual blood loss in IUD users.
    Andrade AT; Pizarro Orchard E
    Contraception; 1987 Jul; 36(1):129-44. PubMed ID: 3311622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Menstrual blood loss, haemoglobin and ferritin concentration of Beijing women wearing steel ring, VCu 200, and TCu 220c IUDs.
    Gao J; Zeng S; Sun BL; Wu SC; Dong J; Cong J; Zhu XH; Fan HM; Han LH; Xie Z
    Contraception; 1986 Dec; 34(6):559-71. PubMed ID: 3829674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of copper surface area on menstrual blood loss and iron status in women fitted with an IUD.
    Milsom I; Rybo G; Lindstedt G
    Contraception; 1990 Mar; 41(3):271-81. PubMed ID: 2323218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Menstrual blood loss and body iron stores: comparative study between a Multiload-375 IUD and a levonorgestrel vaginal ring].
    Souza JP; Andrade AT; Pizarro E
    Bol Cent Biol Reprod; 1991; 10(1):26-32. PubMed ID: 12318141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consequences of uterine blood loss caused by various intrauterine contraceptive devices in South American women. World Health Organization Special Programme of Research, Development and Research Training in Human Reproduction.
    Andrade AT; Pizarro E; Shaw ST; Souza JP; Belsey EM; Rowe PJ
    Contraception; 1988 Jul; 38(1):1-18. PubMed ID: 3048870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of laparoscopic sterilization and insertion of Multiload Cu 250 and Progestasert IUDs on serum ferritin levels.
    Goh TH; Hariharan M
    Contraception; 1983 Oct; 28(4):329-36. PubMed ID: 6667621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A longitudinal study of serum iron indices and haemoglobin concentration following copper-IUD insertion.
    Goh TH; Hariharan M; Tan CH
    Contraception; 1980 Oct; 22(4):389-95. PubMed ID: 7449387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced menstrual blood loss by release of an antifibrinolytic agent from intrauterine contraceptive devices.
    Tauber PF; Kloppel A; Goodpasture JC; Burns J; Ludwig H; Zaneveld LJ
    Am J Obstet Gynecol; 1981 Jun; 140(3):322-8. PubMed ID: 7246636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the levonorgestrel intrauterine device in the prevention and treatment of iron deficiency anemia during fertility regulation.
    Faundes A; Alvarez F; Brache V; Tejada AS
    Int J Gynaecol Obstet; 1988 Jun; 26(3):429-33. PubMed ID: 2900174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The long-term effects of copper surface area on menstrual blood loss and iron status in women fitted with an IUD.
    Larsson G; Milsom I; Jonasson K; Lindstedt G; Rybo G
    Contraception; 1993 Nov; 48(5):471-80. PubMed ID: 8275696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative menstrual and intermenstrual blood loss in women using Lippes Loop and Copper T intrauterine devices.
    Shaw ST; Andrade AT; Paixão de Souza J; Macaulay LK; Rowe PJ
    Contraception; 1980 Apr; 21(4):343-52. PubMed ID: 7389355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evaluation of the levonorgestrel-releasing IUD: its advantages and disadvantages when compared to the copper-releasing IUDs.
    Chi IC
    Contraception; 1991 Dec; 44(6):573-88. PubMed ID: 1773615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Menstrual blood loss in IUD users: comparative study of eleven different IUDs in Mexican women.
    Pedron N
    Adv Contracept Deliv Syst; 1995; 11(3-4):245-53. PubMed ID: 12290877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of the Gyne-T 380S IUD on menstrual blood loss and iron status.
    Milsom I; Andersson K; Jonasson K; Lindstedt G; Rybo G
    Contraception; 1995 Sep; 52(3):175-9. PubMed ID: 7587189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detailed analysis of menstrual bleeding patterns after postmenstrual and postabortal insertion of a copper IUD or a levonorgestrel-releasing intrauterine system.
    Suvisaari J; Lähteenmäki P
    Contraception; 1996 Oct; 54(4):201-8. PubMed ID: 8922872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Menstrual bleeding with copper-covered intrauterine contraceptive devices.
    Malmqvist R; Petersohn L; Bengtsson LP
    Contraception; 1974 Jun; 9(6):627-33. PubMed ID: 4448089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical performance of the TCu 380A and Lippes Loop IUDs in three developing countries.
    Farr G; Amatya R; Acosta M; Ekwempu C; Kisninci H
    Contraception; 1995 Jul; 52(1):17-22. PubMed ID: 8521710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of prior pregnancy and combined oral contraceptives on baseline menstrual blood loss and bleeding response to intrauterine devices.
    Andrade AT; de Souza JP; Rowe PJ; Shaw ST
    Contraception; 1979 Jul; 20(1):19-26. PubMed ID: 477314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Menstrual bleeding pattern and iron status in women fitted with copper and non-medicated intrauterine contraceptive devices.
    Oyelola OO; Okonofua FE; Adediran TO
    East Afr Med J; 1994 Apr; 71(4):268-70. PubMed ID: 8062778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can intrauterine device removals for bleeding or pain be predicted at a one-month follow-up visit? A multivariate analysis.
    Stanback J; Grimes D
    Contraception; 1998 Dec; 58(6):357-60. PubMed ID: 10095972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.